PortalPublikationenPresent results of neutron therapy. The German experience.

Present results of neutron therapy. The German experience.

Standard

Present results of neutron therapy. The German experience. / Schwarz, R; Krüll, Andreas; Heyer, D; Baumann, M; Schmidt, R; Hübener, K H.

in: ACTA ONCOL, Jahrgang 33, Nr. 3, 3, 1994, S. 281-287.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Schwarz, R, Krüll, A, Heyer, D, Baumann, M, Schmidt, R & Hübener, KH 1994, 'Present results of neutron therapy. The German experience.', ACTA ONCOL, Jg. 33, Nr. 3, 3, S. 281-287. <http://www.ncbi.nlm.nih.gov/pubmed/8018356?dopt=Citation>

APA

Schwarz, R., Krüll, A., Heyer, D., Baumann, M., Schmidt, R., & Hübener, K. H. (1994). Present results of neutron therapy. The German experience. ACTA ONCOL, 33(3), 281-287. [3]. http://www.ncbi.nlm.nih.gov/pubmed/8018356?dopt=Citation

Vancouver

Schwarz R, Krüll A, Heyer D, Baumann M, Schmidt R, Hübener KH. Present results of neutron therapy. The German experience. ACTA ONCOL. 1994;33(3):281-287. 3.

Bibtex

@article{a15116e9ab334476abc053928aaaae4c,
title = "Present results of neutron therapy. The German experience.",
abstract = "Results of fast neutron therapy are reviewed with special reference to the main indications for this type of treatment and the experience of five German centers. Neutron therapy seems beneficial compared to conventional radiotherapy in advanced salivary gland tumors, inoperable or unresectable soft tissue sarcomas, some bone tumors, prostate cancer stage C and some rare low-grade tumors. About 3,000 patients with malignancies have been treated with neutrons at the German centers Berlin/Rossendorf, Essen, Hamburg, Heidelberg and M{\"u}nster. Treatment results and treatment-related morbidity depend on the treatment techniques and the physical selectivity of the neutron machines. A critical appraisal suggests that fast neutrons are of advantage in about 5% of all radiotherapy patients.",
keywords = "Germany, Humans, Male, Radiotherapy Dosage, Fast Neutrons/*therapeutic use, Neoplasms/*radiotherapy, Carcinoma, Non-Small-Cell Lung/radiotherapy, Lung Neoplasms/radiotherapy, Paranasal Sinus Neoplasms/radiotherapy, Prostatic Neoplasms/radiotherapy, Rectal Neoplasms/radiotherapy, Salivary Gland Neoplasms/radiotherapy, Sarcoma/radiotherapy, Spinal Cord Neoplasms/radiotherapy, Germany, Humans, Male, Radiotherapy Dosage, Fast Neutrons/*therapeutic use, Neoplasms/*radiotherapy, Carcinoma, Non-Small-Cell Lung/radiotherapy, Lung Neoplasms/radiotherapy, Paranasal Sinus Neoplasms/radiotherapy, Prostatic Neoplasms/radiotherapy, Rectal Neoplasms/radiotherapy, Salivary Gland Neoplasms/radiotherapy, Sarcoma/radiotherapy, Spinal Cord Neoplasms/radiotherapy",
author = "R Schwarz and Andreas Kr{\"u}ll and D Heyer and M Baumann and R Schmidt and H{\"u}bener, {K H}",
year = "1994",
language = "English",
volume = "33",
pages = "281--287",
journal = "ACTA ONCOL",
issn = "0284-186X",
publisher = "informa healthcare",
number = "3",

}

RIS

TY - JOUR

T1 - Present results of neutron therapy. The German experience.

AU - Schwarz, R

AU - Krüll, Andreas

AU - Heyer, D

AU - Baumann, M

AU - Schmidt, R

AU - Hübener, K H

PY - 1994

Y1 - 1994

N2 - Results of fast neutron therapy are reviewed with special reference to the main indications for this type of treatment and the experience of five German centers. Neutron therapy seems beneficial compared to conventional radiotherapy in advanced salivary gland tumors, inoperable or unresectable soft tissue sarcomas, some bone tumors, prostate cancer stage C and some rare low-grade tumors. About 3,000 patients with malignancies have been treated with neutrons at the German centers Berlin/Rossendorf, Essen, Hamburg, Heidelberg and Münster. Treatment results and treatment-related morbidity depend on the treatment techniques and the physical selectivity of the neutron machines. A critical appraisal suggests that fast neutrons are of advantage in about 5% of all radiotherapy patients.

AB - Results of fast neutron therapy are reviewed with special reference to the main indications for this type of treatment and the experience of five German centers. Neutron therapy seems beneficial compared to conventional radiotherapy in advanced salivary gland tumors, inoperable or unresectable soft tissue sarcomas, some bone tumors, prostate cancer stage C and some rare low-grade tumors. About 3,000 patients with malignancies have been treated with neutrons at the German centers Berlin/Rossendorf, Essen, Hamburg, Heidelberg and Münster. Treatment results and treatment-related morbidity depend on the treatment techniques and the physical selectivity of the neutron machines. A critical appraisal suggests that fast neutrons are of advantage in about 5% of all radiotherapy patients.

KW - Germany

KW - Humans

KW - Male

KW - Radiotherapy Dosage

KW - Fast Neutrons/therapeutic use

KW - Neoplasms/radiotherapy

KW - Carcinoma, Non-Small-Cell Lung/radiotherapy

KW - Lung Neoplasms/radiotherapy

KW - Paranasal Sinus Neoplasms/radiotherapy

KW - Prostatic Neoplasms/radiotherapy

KW - Rectal Neoplasms/radiotherapy

KW - Salivary Gland Neoplasms/radiotherapy

KW - Sarcoma/radiotherapy

KW - Spinal Cord Neoplasms/radiotherapy

KW - Germany

KW - Humans

KW - Male

KW - Radiotherapy Dosage

KW - Fast Neutrons/therapeutic use

KW - Neoplasms/radiotherapy

KW - Carcinoma, Non-Small-Cell Lung/radiotherapy

KW - Lung Neoplasms/radiotherapy

KW - Paranasal Sinus Neoplasms/radiotherapy

KW - Prostatic Neoplasms/radiotherapy

KW - Rectal Neoplasms/radiotherapy

KW - Salivary Gland Neoplasms/radiotherapy

KW - Sarcoma/radiotherapy

KW - Spinal Cord Neoplasms/radiotherapy

M3 - SCORING: Journal article

VL - 33

SP - 281

EP - 287

JO - ACTA ONCOL

JF - ACTA ONCOL

SN - 0284-186X

IS - 3

M1 - 3

ER -